Day & Ennis’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.92M Sell
18,642
-97
-0.5% -$14.9K 1.03% 23
2023
Q3
$2.92M Sell
18,739
-1,217
-6% -$201K 1.09% 23
2023
Q2
$3.3M Buy
19,956
+20
+0.1% +$3.23K 1.26% 19
2023
Q1
$3.09M Buy
19,936
+51
+0.3% +$8.23K 1.14% 22
2022
Q4
$3.51M Buy
19,885
+315
+2% +$54.4K 1.36% 19
2022
Q3
$3.2M Sell
19,570
-61
-0.3% -$10.3K 1.33% 24
2022
Q2
$3.48M Buy
19,631
+36
+0.2% +$6.41K 1.32% 25
2022
Q1
$3.47M Sell
19,595
-168
-0.9% -$28.6K 1.15% 30
2021
Q4
$3.38M Buy
19,763
+216
+1% +$35.4K 1.11% 30
2021
Q3
$3.16M Buy
19,547
+277
+1% +$47.3K 1.09% 30
2021
Q2
$3.17M Buy
19,270
+316
+2% +$52.3K 1.1% 28
2021
Q1
$3.12M Buy
18,954
+275
+1% +$44.5K 1.18% 27
2020
Q4
$2.94M Buy
18,679
+558
+3% +$82.3K 1.17% 29
2020
Q3
$2.7M Buy
18,121
+137
+0.8% +$20.3K 1.17% 29
2020
Q2
$2.53M Buy
17,984
+324
+2% +$47.2K 1.25% 25
2020
Q1
$2.32M Sell
17,660
-1,941
-10% -$275K 1.32% 23
2019
Q4
$2.86M Buy
19,601
+99
+0.5% +$13.4K 1.4% 23
2019
Q3
$2.52M Buy
19,502
+10
+0.1% +$1.32K 1.3% 26
2019
Q2
$2.71M Sell
19,492
-157
-0.8% -$21.7K 1.43% 25
2019
Q1
$2.75M Sell
19,649
-22
-0.1% -$2.95K 1.54% 21
2018
Q4
$2.54M Sell
19,671
-40
-0.2% -$5.58K 1.67% 21
2018
Q3
$2.72M Sell
19,711
-469
-2% -$62.3K 1.83% 17
2018
Q2
$2.45M Buy
20,180
+824
+4% +$103K 1.82% 17
2018
Q1
$2.48M Buy
19,356
+26
+0.1% +$3.51K 2.03% 15
2017
Q4
$2.7M Buy
19,330
+262
+1% +$36.5K 2.21% 9
2017
Q3
$2.48M Sell
19,068
-3,544
-16% -$470K 2.19% 9
2017
Q2
$2.99M Buy
22,612
+98
+0.4% +$12.5K 2.58% 7
2017
Q1
$2.8M Buy
22,514
+43
+0.2% +$5.14K 2.66% 7
2016
Q4
$2.59M Buy
22,471
+734
+3% +$84.8K 2.65% 8
2016
Q3
$2.57M Buy
21,737
+1,286
+6% +$156K 2.7% 8
2016
Q2
$2.48M Sell
20,451
-12
-0.1% -$1.36K 2.69% 9
2016
Q1
$2.21M Sell
20,463
-488
-2% -$50.5K 2.45% 10
2015
Q4
$2.15M Buy
+20,951
New +$2.11M 2.41% 11

Other funds holding JNJ

Day & Ennis's JNJ Position: Q4 2023 in Review

Day & Ennis reduced its Johnson & Johnson (JNJ) stake by 0.52% in Q4 2023, selling an estimated $14.9K and leaving 18,642 shares worth $2.92M. The position accounts for 1.03% of the portfolio, ranked #23.

Day & Ennis first reported a position in JNJ in Q4 2015 and has held it in 33 quarters since. The position peaked at $3.51M in Q4 2022. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Day & Ennis held 18,642 shares of Johnson & Johnson worth $2.92M as of Q4 2023.
  • Day & Ennis sold 97 Johnson & Johnson shares in Q4 2023, an estimated $14.9K.
  • Johnson & Johnson made up 1.03% of Day & Ennis's portfolio in Q4 2023, its #23 holding.
  • Day & Ennis first reported a position in Johnson & Johnson in Q4 2015 and has held it in 33 quarters since.
  • Day & Ennis's Johnson & Johnson position peaked at $3.51M in Q4 2022.
  • 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Day & Ennis's 13F filing for Q4 2023, filed 18 Jan 2024.